ARCUTIS BIOTHERAPEUTICS INC (ARQT) Stock Income Statement
NASDAQ:ARQT - Nasdaq - US03969K1088 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 212.82M | 196.54M | 59.61M | 3.69M | 0.00 | |||
| Cost Of Goods | 24.70M | 19.13M | 4.99M | 750.00K | N/A | |||
| Gross Profit | 188.12M | 177.41M | 54.62M | 2.93M | N/A | |||
| Operating Expenses | 309.42M | 305.81M | 295.72M | 304.56M | 206.53M | |||
| Research and Development | 70.82M | 76.42M | 110.58M | 182.44M | 145.56M | |||
| Selling, General, and Administrative Expenses | 238.60M | 229.39M | 185.15M | 122.12M | 60.97M | |||
| Operating Income | -121.30M | -128.40M | -241.10M | -301.63M | -206.53M | |||
| Interest Income/Expense | -22.67M | -27.17M | -29.71M | -15.65M | N/A | |||
| Other Income/Expense | 14.86M | 16.17M | 11.79M | 5.82M | 170.00K | |||
| Income Before Taxes | -129.12M | -139.39M | -259.03M | -311.46M | -206.36M | |||
| Income Tax | 602.00K | 647.00K | 3.11M | N/A | N/A | |||
| Net Income | -129.72M | -140.04M | -262.14M | -311.46M | -206.36M | |||
| EBITDA | -115.93M | -125.80M | -239.58M | -300.70M | -206.08M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.04 | -1.16 | -3.78 | -5.66 | -4.18 | |||
| Non GAAP EPS | -1.04 | -1.16 | -3.92 | -5.65 | -4.16 | |||
| Statistics | ||||||||
| Gross Profit Margin | 88.39% | 90.27% | 91.63% | 79.40% | N/A | |||
| Profit Margin | -60.95% | -71.25% | -439.79% | -8440.65% | N/A | |||
| Operating Profit Margin | -57.00% | -65.33% | -404.49% | -8174.25% | N/A | |||
All data in USD